CORBION NV (CRBN.AS) Stock Fundamental Analysis

Europe • Euronext Amsterdam • AMS:CRBN • NL0010583399

20.37 EUR
-0.11 (-0.54%)
Last: Feb 3, 2026, 12:13 PM
Fundamental Rating

5

Taking everything into account, CRBN scores 5 out of 10 in our fundamental rating. CRBN was compared to 68 industry peers in the Chemicals industry. CRBN has an average financial health and profitability rating. CRBN is cheap, but on the other hand it scores bad on growth. This makes CRBN very considerable for value investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year CRBN was profitable.
  • CRBN had a positive operating cash flow in the past year.
  • In the past 5 years CRBN has always been profitable.
  • CRBN had a positive operating cash flow in each of the past 5 years.
CRBN.AS Yearly Net Income VS EBIT VS OCF VS FCFCRBN.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

  • The Return On Assets of CRBN (4.57%) is better than 70.59% of its industry peers.
  • Looking at the Return On Equity, with a value of 9.14%, CRBN is in the better half of the industry, outperforming 69.12% of the companies in the same industry.
  • CRBN has a better Return On Invested Capital (9.22%) than 76.47% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CRBN is in line with the industry average of 6.72%.
  • The last Return On Invested Capital (9.22%) for CRBN is above the 3 year average (6.62%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.57%
ROE 9.14%
ROIC 9.22%
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
CRBN.AS Yearly ROA, ROE, ROICCRBN.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • CRBN's Profit Margin of 5.12% is fine compared to the rest of the industry. CRBN outperforms 66.18% of its industry peers.
  • CRBN's Profit Margin has improved in the last couple of years.
  • CRBN's Operating Margin of 8.70% is fine compared to the rest of the industry. CRBN outperforms 64.71% of its industry peers.
  • In the last couple of years the Operating Margin of CRBN has declined.
  • With a Gross Margin value of 26.10%, CRBN is not doing good in the industry: 60.29% of the companies in the same industry are doing better.
  • CRBN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.7%
PM (TTM) 5.12%
GM 26.1%
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
CRBN.AS Yearly Profit, Operating, Gross MarginsCRBN.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CRBN is still creating some value.
  • CRBN has less shares outstanding than it did 1 year ago.
  • CRBN has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, CRBN has an improved debt to assets ratio.
CRBN.AS Yearly Shares OutstandingCRBN.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CRBN.AS Yearly Total Debt VS Total AssetsCRBN.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • CRBN has an Altman-Z score of 2.84. This is not the best score and indicates that CRBN is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of CRBN (2.84) is better than 60.29% of its industry peers.
  • CRBN has a debt to FCF ratio of 4.92. This is a neutral value as CRBN would need 4.92 years to pay back of all of its debts.
  • CRBN has a Debt to FCF ratio of 4.92. This is in the better half of the industry: CRBN outperforms 75.00% of its industry peers.
  • A Debt/Equity ratio of 0.39 indicates that CRBN is not too dependend on debt financing.
  • CRBN has a Debt to Equity ratio of 0.39. This is comparable to the rest of the industry: CRBN outperforms 58.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 4.92
Altman-Z 2.84
ROIC/WACC1.39
WACC6.62%
CRBN.AS Yearly LT Debt VS Equity VS FCFCRBN.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

  • CRBN has a Current Ratio of 1.21. This is a normal value and indicates that CRBN is financially healthy and should not expect problems in meeting its short term obligations.
  • CRBN's Current ratio of 1.21 is on the low side compared to the rest of the industry. CRBN is outperformed by 77.94% of its industry peers.
  • A Quick Ratio of 0.60 indicates that CRBN may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.60, CRBN is not doing good in the industry: 85.29% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.6
CRBN.AS Yearly Current Assets VS Current LiabilitesCRBN.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

  • The earnings per share for CRBN have decreased strongly by -68.92% in the last year.
  • CRBN shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 49.47% yearly.
  • Looking at the last year, CRBN shows a small growth in Revenue. The Revenue has grown by 2.95% in the last year.
  • Measured over the past years, CRBN shows a small growth in Revenue. The Revenue has been growing by 5.70% on average per year.
EPS 1Y (TTM)-68.92%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-74.51%
Revenue 1Y (TTM)2.95%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%1.33%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.24% on average over the next years. This is quite good.
  • Based on estimates for the next years, CRBN will show a decrease in Revenue. The Revenue will decrease by -1.71% on average per year.
EPS Next Y36.96%
EPS Next 2Y22.71%
EPS Next 3Y19.54%
EPS Next 5Y15.24%
Revenue Next Year-2.4%
Revenue Next 2Y-0.19%
Revenue Next 3Y1.19%
Revenue Next 5Y-1.71%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CRBN.AS Yearly Revenue VS EstimatesCRBN.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B
CRBN.AS Yearly EPS VS EstimatesCRBN.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 18.19 indicates a rather expensive valuation of CRBN.
  • CRBN's Price/Earnings ratio is a bit cheaper when compared to the industry. CRBN is cheaper than 69.12% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 28.41. CRBN is valued slightly cheaper when compared to this.
  • The Price/Forward Earnings ratio is 13.44, which indicates a correct valuation of CRBN.
  • 82.35% of the companies in the same industry are more expensive than CRBN, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 25.64. CRBN is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 18.19
Fwd PE 13.44
CRBN.AS Price Earnings VS Forward Price EarningsCRBN.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • CRBN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CRBN is cheaper than 70.59% of the companies in the same industry.
  • CRBN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CRBN is cheaper than 94.12% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.82
EV/EBITDA 8.35
CRBN.AS Per share dataCRBN.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • CRBN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of CRBN may justify a higher PE ratio.
  • CRBN's earnings are expected to grow with 19.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.49
PEG (5Y)0.37
EPS Next 2Y22.71%
EPS Next 3Y19.54%

More info and screens

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 3.20%, CRBN has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 2.28, CRBN pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.83, CRBN pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.2%

5.2 History

  • The dividend of CRBN has a limited annual growth rate of 5.02%.
Dividend Growth(5Y)5.02%
Div Incr Years1
Div Non Decr Years5
CRBN.AS Yearly Dividends per shareCRBN.AS Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

  • CRBN pays out 56.02% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • The dividend of CRBN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP56.02%
EPS Next 2Y22.71%
EPS Next 3Y19.54%
CRBN.AS Yearly Income VS Free CF VS DividendCRBN.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M
CRBN.AS Dividend Payout.CRBN.AS Dividend Payout, showing the Payout Ratio.CRBN.AS Dividend Payout.PayoutRetained Earnings

More info and screens

CORBION NV

AMS:CRBN (2/3/2026, 12:13:02 PM)

20.37

-0.11 (-0.54%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-31
Earnings (Next)02-26
Inst Owners92.92%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap1.19B
Revenue(TTM)1.30B
Net Income(TTM)66.40M
Analysts78.57
Price Target23.92 (17.43%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.2%
Yearly Dividend0.71
Dividend Growth(5Y)5.02%
DP56.02%
Div Incr Years1
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)4.96%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.26%
EPS NY rev (3m)-1.15%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.44%
Valuation
Industry RankSector Rank
PE 18.19
Fwd PE 13.44
P/S 0.92
P/FCF 11.82
P/OCF 7.03
P/B 1.63
P/tB 1.87
EV/EBITDA 8.35
EPS(TTM)1.12
EY5.5%
EPS(NY)1.52
Fwd EY7.44%
FCF(TTM)1.72
FCFY8.46%
OCF(TTM)2.9
OCFY14.22%
SpS22.26
BVpS12.47
TBVpS10.88
PEG (NY)0.49
PEG (5Y)0.37
Graham Number17.72
Profitability
Industry RankSector Rank
ROA 4.57%
ROE 9.14%
ROCE 10.95%
ROIC 9.22%
ROICexc 9.59%
ROICexgc 10.58%
OM 8.7%
PM (TTM) 5.12%
GM 26.1%
FCFM 7.74%
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
ROICexc(3y)7.16%
ROICexc(5y)7.83%
ROICexgc(3y)8.31%
ROICexgc(5y)9.44%
ROCE(3y)7.87%
ROCE(5y)8.47%
ROICexgc growth 3Y0.82%
ROICexgc growth 5Y-11.84%
ROICexc growth 3Y3.78%
ROICexc growth 5Y-8.06%
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
F-Score6
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 4.92
Debt/EBITDA 1.43
Cap/Depr 80.83%
Cap/Sales 5.27%
Interest Coverage 7.23
Cash Conversion 85.5%
Profit Quality 151.21%
Current Ratio 1.21
Quick Ratio 0.6
Altman-Z 2.84
F-Score6
WACC6.62%
ROIC/WACC1.39
Cap/Depr(3y)194.04%
Cap/Depr(5y)192.31%
Cap/Sales(3y)11.51%
Cap/Sales(5y)11.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.92%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-74.51%
EPS Next Y36.96%
EPS Next 2Y22.71%
EPS Next 3Y19.54%
EPS Next 5Y15.24%
Revenue 1Y (TTM)2.95%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%1.33%
Revenue Next Year-2.4%
Revenue Next 2Y-0.19%
Revenue Next 3Y1.19%
Revenue Next 5Y-1.71%
EBIT growth 1Y54.95%
EBIT growth 3Y8.15%
EBIT growth 5Y1.31%
EBIT Next Year128.83%
EBIT Next 3Y37.35%
EBIT Next 5Y26.73%
FCF growth 1Y172.18%
FCF growth 3YN/A
FCF growth 5Y21.2%
OCF growth 1Y119.09%
OCF growth 3Y101.81%
OCF growth 5Y9.98%

CORBION NV / CRBN.AS FAQ

What is the fundamental rating for CRBN stock?

ChartMill assigns a fundamental rating of 5 / 10 to CRBN.AS.


What is the valuation status of CORBION NV (CRBN.AS) stock?

ChartMill assigns a valuation rating of 7 / 10 to CORBION NV (CRBN.AS). This can be considered as Undervalued.


What is the profitability of CRBN stock?

CORBION NV (CRBN.AS) has a profitability rating of 6 / 10.


What is the earnings growth outlook for CORBION NV?

The Earnings per Share (EPS) of CORBION NV (CRBN.AS) is expected to grow by 36.96% in the next year.


How sustainable is the dividend of CORBION NV (CRBN.AS) stock?

The dividend rating of CORBION NV (CRBN.AS) is 6 / 10 and the dividend payout ratio is 56.02%.